rs11638981
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001193489.2(SECISBP2L):c.665-650A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.204 in 152,194 control chromosomes in the GnomAD database, including 3,904 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.20 ( 3904 hom., cov: 32)
Consequence
SECISBP2L
NM_001193489.2 intron
NM_001193489.2 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.296
Publications
8 publications found
Genes affected
SECISBP2L (HGNC:28997): (SECIS binding protein 2 like) Enables RNA binding activity. Predicted to be involved in selenocysteine incorporation. Predicted to be part of ribonucleoprotein complex. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.287 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| SECISBP2L | ENST00000559471.6 | c.665-650A>G | intron_variant | Intron 4 of 17 | 1 | NM_001193489.2 | ENSP00000453854.1 | |||
| SECISBP2L | ENST00000261847.7 | c.665-650A>G | intron_variant | Intron 4 of 16 | 1 | ENSP00000261847.3 | ||||
| SECISBP2L | ENST00000380927.6 | c.-50-650A>G | intron_variant | Intron 4 of 16 | 1 | ENSP00000370314.2 | ||||
| SECISBP2L | ENST00000559424.1 | c.611-845A>G | intron_variant | Intron 4 of 8 | 1 | ENSP00000452987.1 |
Frequencies
GnomAD3 genomes AF: 0.204 AC: 31015AN: 152076Hom.: 3903 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
31015
AN:
152076
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.204 AC: 31014AN: 152194Hom.: 3904 Cov.: 32 AF XY: 0.207 AC XY: 15392AN XY: 74404 show subpopulations
GnomAD4 genome
AF:
AC:
31014
AN:
152194
Hom.:
Cov.:
32
AF XY:
AC XY:
15392
AN XY:
74404
show subpopulations
African (AFR)
AF:
AC:
2402
AN:
41554
American (AMR)
AF:
AC:
3214
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
AC:
897
AN:
3468
East Asian (EAS)
AF:
AC:
1020
AN:
5174
South Asian (SAS)
AF:
AC:
1444
AN:
4818
European-Finnish (FIN)
AF:
AC:
3100
AN:
10576
Middle Eastern (MID)
AF:
AC:
89
AN:
294
European-Non Finnish (NFE)
AF:
AC:
18206
AN:
68002
Other (OTH)
AF:
AC:
484
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1191
2382
3573
4764
5955
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
346
692
1038
1384
1730
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
759
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.